Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Trends Mol Med. 2013 Sep 26;19(11):10.1016/j.molmed.2013.08.007. doi: 10.1016/j.molmed.2013.08.007

Table 1.

TRAIL modifications that enable detection and/or improve therapeutic performance.

Name Modification Improvement Application Refs
LZ-TRAIL Addition of a leucine zipper Efficacy Facilitated trimerization, activity and stability in vitro and in vivo [8]
[125I]rhTRAIL Radioiodinated recombinant human TRAIL Detection In vivo biodistribution and clearance [18]
FLAG-TRAIL Addition of FLAG tag to TRAIL Efficacy FLAG tag allows cross linking of TRAIL by using an anti-FLAG antibody [19]
S-TRAIL-GFP Fusion of the extracellular domain of Flt3L and an isoleucine zipper to the N-terminus of TRAIL. GFP fused to C-terminus Efficacy + Detection Enhanced apoptosis via bystander effect and stabilized oligomerization of TRAIL. GFP expression allows visualization of TRAIL-expressing cells [20]
iz-TRAIL Addition of an isoleucine zipper Efficacy Facilitated oligomerization resulting in improved cytotoxicity [21]
scFv-sTRAIL scFv-sTRAIL bifunctional fusion proteins Efficacy Increased specificity and strength of TRAIL response. Permits paracrine signaling [23, 69]
HSA-Flag-TNC-TRAIL Human serum albumin genetically fused to N-terminus of secretable TRAIL Efficacy Increased serum halflife to improve bioavailability [24]
Transferrin-PEG-TRAIL (Tf-PEG10K-TRAIL) PEGylated TRAIL attached to transferrin Efficacy + Targeting Combined tumor targeting/killing properties [25]
PEG-TRAIL PEGylation of TRAIL with PEGa of different molecular weights Efficacy + Longevity Increased serum half-life and protracted activity in vivo [26]
TRAIL-loaded PLGAb microspheres Nanocomplex system Efficacy + Longevity Sustained TRAIL release and tumor killing properties in vivo [27]
SRL0L2TR Luciferase fused to the N-terminus of secretable TRAIL Detection Direct extracellular visualization and monitoring of levels, time of delivery and localization of stem cell-delivered proteins by bioluminescent imaging [38]
pORF-hTRAIL Multifunctional nanoparticle comprising doxorubicin (DOX) and pORF-hTRAIL Efficacy Anti-glioma efficacy in vivo. Low pH conditions, such as those found in tumors, result in fast DOX release via cleavage of a pH-sensitive hydrazine bond [49]
TRAIL-UCA Ultrasound contrast agents chemically conjugated to TRAIL Detection Tracked by ultrasound imaging and fragmented into nanoparticles by focused ultrasound [71]
Nanoparticle-TRAIL TRAIL conjugated to nanoparticles Efficacy Enhances anti-tumor activity in glioma and glioma stem cells in vitro and in vivo [72]
a

PEG, Polyethylene glycol.

b

PLGA, poly(lactic-co-glycolic acid).